The aim of this study is to compare the efficacy and safety of a novel anti-HER2 antibody drug conjugate combined with HP (pertuzumab and trastuzumab) chem
Additional analyses from the CheckMate 9DW study shed further light on the clinical efficacy and safety of ipi/nivo for uHCC.
Enrollment is underway for a clinical trial that will evaluate whether smartwatch technology can allow for earlier detection of lymphedema.Lymphedema — a common complication that…
OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.
Drug is approved in combination with fludarabine
Summary:. As we cannot reliably distinguish indolent, low-risk ductal carcinoma in situ (DCIS) from potentially progressive, high-risk DCIS, all women with DCIS diagnosis undergo intensive…
Smartwatches have transformed the way many people communicate and track their health habits. Now researchers at OSUCCC – James are testing whether these
Calling all eye care professionals looking to attend the CRU Eye Symposium this year! Are you curious about which wine matches your personality? Find out…
Neoadjuvant sintilimab plus chemoradiotherapy improved pCR rates in resectable, locally advanced esophageal squamous cell carcinoma.
Learn about PFOA (and similar PFAS chemicals such as PFOS) and their possible effects on cancer risk here.
The burden of cancer is growing in Africa because of the aging and growth of the population, as well as the adoption of “westernized” lifestyles…
